Nutriop

Longevity Leaders Congress – longevity in sharp focus

Latest articles

Dyno Therapeutics closes $100m to accelerate gene therapy

Dyno Therapeutics closes $100 million Series A led by Andreessen Horowitz to accelerate AI-powered gene therapy platform. Dyno Therapeutics, Inc, a biotech applying AI to...

Sticking with glutathione could be a smart longevity choice

The body's "master antioxidant" glutathione is a powerful weapon in the fight for longevity, but it diminishes with age; AgelessRx has a range of...

Rise of the retrons – a new gene editing technique

Move over CRISPR... a new gene editing technique enables millions of genetic experiments to be performed simultaneously. Like the best B Movie ever, The Day...

VitaDAO announces “Longevity Molecule” research project

VitaDAO will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan. VitaDAO, which...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Dyno Therapeutics closes $100m to accelerate gene therapy

Dyno Therapeutics closes $100 million Series A led by Andreessen Horowitz to accelerate AI-powered gene therapy platform. Dyno Therapeutics, Inc, a biotech applying AI to...

Sticking with glutathione could be a smart longevity choice

The body's "master antioxidant" glutathione is a powerful weapon in the fight for longevity, but it diminishes with age; AgelessRx has a range of...

Rise of the retrons – a new gene editing technique

Move over CRISPR... a new gene editing technique enables millions of genetic experiments to be performed simultaneously. Like the best B Movie ever, The Day...
Nutriop

The third annual Longevity Leaders World Congress is set to bring together the topics of  Aging Science, Aging Well and Financing Longevity.

Framed as “the event for leaders in longevity science, technology, business and finance”, the third annual Longevity Leaders congress kicks off tomorrow.

Running from 4-7 May, and delivered virtually, the list of speakers is a Who’s Who of Longevity. Sergey Young, Nir Barzilai, Lynne Cox, Aubrey de Grey, Michael Hufford, James Kirkland, João Pedro de Magalhães, Ronjon Nag, Janet Lord, Joan Mannick, Eric Verdin… far too many to keep listing!

Longevity.Technology: Longevity Leaders are a global network of influential leaders from the worlds of aging science, consumer products, finance, technology and investment. Their mission is to advance innovations that will extend human health span and enable financial, physical and mental wellness in later life. Longevity Leaders is a subsidiary of LSX, an influential community of senior life science decision makers.

The COVID-19 pandemic has thrown aging and longevity into sharp public focus. The congress is of the opinion that it is now critical that we understand the biology of aging to improve the underlying health of our populations, improve immune response and reduce disease. We would agree with their view that financial wellbeing and security in later life urgently needs attention.

In addition, the care sector is in desperate need of innovation and support; the way that we work and connect with one another has shifted dramatically and permanently, with significant implications for aging populations. The congress will be exploring this topic in some depth.

The Longevity Leaders World Congress is the definitive global meeting with the mission of extending human health span, delivering healthy aging and financial wellness in the context of longevity. As three-conferences-in-one, it digs deeply into each facet while shared plenary and networking sessions provide opportunities for interdisciplinary exchange:

Ageing Science
Ageing Well
Financing Longevity

Some of our must-see agenda items include:

What is the longevity dividend, and where are the opportunities for investors?

VCs explain where they see the greatest areas of opportunity for entrepreneurs to access the longevity dividend, and what companies need to demonstrate to secure investment – featuring Joachim Rautter and Petr Sramek, among others.

Why innovation makes me excited about getting older

When we talk about innovating for later life, too often we think about it in terms of “other”. But if we’re lucky we’re all going to get there, so why aren’t we designing products and services with ourselves in mind? This session focuses on emerging innovation for older consumers and what corporate stakeholders are seeing to make them excited for later life – featuring Margarita Skarkou and Jackie Marshall-Cyrus, and moderated by founder of The Gerotechnologist, Keren Etkin.

Investing in longevity biotech – market opportunities, gaps and priorities

The world’s most prominent investors in longevity biotech share their thoughts on the biggest areas of opportunity, gaps in the market and framing priorities to bring more investment into the field – featuring Aubrey De Grey, Ronjon Nag and Alexandra Bause, among others.

Special session: 7 Signs of Longevity Revolution

We have entered a new and exciting time. Tech breakthroughs are changing the face of medicine and making it possible for us to cure previously fatal diseases. The longevity revolution means we will all be living longer and healthier than ever before! With Sergey Young, Founder, Longevity Vision Fund.

Changing the narrative on ageing science to secure funding for fundamental research

COVID-19 has changed the narrative on the biology of ageing and its impact on health. This session explores how to better communicate the concept of ageing science to funding bodies in the wake of COVID-19, encouraging open dialogue between researchers and funding bodies – featuring João Pedro de Magalhães and Claire Stewart, and moderated by Lynne Cox.

Register for the conference here. Choose from a free content pass, an investor access pass, a premium access pass or Premium + showcase pass. 

Image credit: Dan NelsonPixabay and Longevity Leaders

 

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Nutriop

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Supplement report

Related articles

Healthy longevity policy recommendation gains EU traction

A recommendation for a commitment to longevity research, focused geroprotective clinical trials and fair access to both is gaining traction in the EU. The Conference...

Networking at a senescent level

The Senolytic Therapy Network is advancing the fight against aging with outreach and research initiatives – we speak to a co-founder. The Senolytic Therapy Network...

Metallomics Symposium has implications for longevity

King's Together Strategic Award Virtual Symposium: 'Metal Fingerprints in Normal Cell States and Disease' – a Virtual Symposium hosted by the London Metallomics Facility,...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity pharmacology “promises to revolutionize medicine”

Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin, Calico and human trials. The longevity space is...
Nutriop